Hong Wang
Shanghai Jiao Tong University
14 Papers
28 Citations
Hong Wang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Medicine & Retinal detachment. The author has an hindex of 4, co-authored 10 publications.
Chat about Author
Papers
Macular perfusion changes assessed with optical coherence tomography angiography after vitrectomy for rhegmatogenous retinal detachment
TL;DR: Macular perfusion gradually recovered following successful RRD repair by PPV and OCTA provided a non-invasive method to explore the underlying reason for different postoperative visual outcomes in macular-off RRD patients.
Testing toxicity of multiple intravitreal injections of bevacizumab in rabbit eyes
Weiqi Xu,Hong Wang,Fenghua Wang,Yuan Jiang,Xian Zhang,Wenqiu Wang,Jin Qian,Xun Xu,Xiaodong Sun +8 more
TL;DR: The biweekly, multiple intravitreal injections of bevacizumab did not result in evidence of toxicity in regular clinical and functional observations, and the 5.0 mg dose may induce transient inflammation, ultrastructural abnormalities, and apoptosis.
21
Axial length/corneal radius of curvature ratio and refractive development evaluation in 3- to 4-year-old children: the Shanghai Pudong Eye Study.
TL;DR: VA and AL/CRC ratio reference could be used to assess refractive development in children and screening uncorrected refractive errors or amblyopia and astigmatism needs to be considered in the diagnosis.
17
Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
TL;DR: IGFBP-rP1 inhibits retinal angiogenesis by blocking ERK signaling pathway and downregulating VEGF expression in the mouse model of OIR, highlighting the potential importance of IGFBP- rP1 serving as a target of gene therapy for retinal neovascularization in the future.
8
Inverted internal limiting membrane insertion combined with air tamponade in the treatment of macular hole retinal detachment in high myopia: study protocol for a randomized controlled clinical trial
TL;DR: This trial may provide a novel surgical treatment for MHRD in high myopia with more effectiveness and less pain and compare the efficacy with that of the conventional “vitrectomy plus internal limiting membrane peeling plus silicone oil tamponade” method.